Transcription of [P] Midazolam - Palliative Care
{{id}} {{{paragraph}}}
Example: tourism industry
[P] Midazolam - Palliative Care
Medi cati on & Admi ni s trati on Medi ci nes & Infus i on Protocol s (Adul ts )/ 1d Pal l iati ve Care Midazolam subcutaneous and Nasal- Palliative Care (Adults) 36 Issued by Pharmacy & Hospital Palliative Care Team Issued Date July 2016 Classification 014-001-01-073 Authorised by P&T Committee Review Period 36 months Page 1 of 6 This information is correct at date of issue. Always check on Waitemata DHB Controlled Documents site that this is the most recent version. Contents 1. Overview .. 1 2. Presentation .. 1 3. Indications .. 2 4. Dose .. 2 subcutaneous Mi dazolam ..2 Mi dazol am Nasal Spray ..2 Dos e Convers i 5. Administration .. 3 Dil uent ..3 Addi ti onal Equi Compati bili ty ..3 Admi ni s trati on Procedure ..4 6. Observation and Monitoring .. 4 7. Mechanism of 4 8. Contraindications and Precautions .. 4 9. Possible Adverse Effects.
Inject through a Saf-T-Intima (butterfly) or directly via subcutaneous needle. The Saf-T-Intima should be flushed with 0.2ml of water for injection after administration of medication. Can be administered via a continuous subcutaneous infusion pump (Niki T34). Intranasal administration Ensure patient is seated upright with head upright.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: